EU/U.S. Trade Pact Talks May Stumble Over Drug Regulation, Affordability
This article was originally published in The Pink Sheet Daily
Executive Summary
The EU Parliament’s health committee has highlighted regulatory pitfalls within TTIP, while civil society elements decry its lack of transparency and potential impact on health care affordability.